SCHEMBL5686123

SCHEMBL5686123

C=C(C#N)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL26984280 0.79 GLRA1 (0.31)
SCHEMBL20940099 0.75
SCHEMBL25473216 0.75
Ethylenediamine SCHEMBL890980 0.73 TDP1 (0.32)
SCHEMBL10911854 0.72 TDP1 (0.41)
SCHEMBL7772551 0.71
SCHEMBL501742 0.69
SCHEMBL11803858 0.69
SCHEMBL17291902 0.69
SCHEMBL11499401 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188040-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS INC 2025-06-12 US disclosed
EP-4551555-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS Vividion Therapeutics, Inc. (US) 2025-05-14 EP disclosed
CN-119677716-A Pharmaceutical compositions comprising WRN helicase inhibitors 维维迪恩医疗公司 2025-03-21 CN disclosed
US-20250026721-A1 COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K VIVIDION THERAPEUTICS, INC. 2025-01-23 US disclosed
US-12187685-B2 Pharmaceutical compositions comprising WRN helicase inhibitors VIVIDION THERAPEUTICS, INC. 2025-01-07 US disclosed
US-20240140915-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-05-02 US disclosed
US-20240067612-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-02-29 US disclosed
US-20240067612-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-02-29 US disclosed
US-20240067612-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-02-29 US disclosed
WO-2024010782-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed
EP-0789275-A1 Method for processing silver halide color light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1997-08-13 EP disclosed
US-5556913-A CURABLE CATIONIC POLYMERS TO FORM FILMS NIPPON PAINT CO., LTD. (JP) 1996-09-17 US disclosed
EP-0431554-B1 Cationic electrocoating composition NIPPON PAINT CO LTD (JP) 1994-04-06 EP disclosed
EP-0431554-A2 Cationic electrocoating composition NIPPON PAINT CO., LTD. (JP) 1991-06-12 EP disclosed
US-4391812-A ANTIINFLAMMATORY AGENTS MERCK & CO., INC. (US) 1983-07-05 US disclosed
US-4342872-A ANTIMICROBIAL AGENTS MERCK & CO., INC. (US) 1982-08-03 US disclosed
US-4342873-A MICROBIOCIDES MERCK & CO., INC. (US) 1982-08-03 US disclosed
EP-0024356-A1 Pharmaceutical composition for treating a condition exhibiting pain, fever, and inflammation comprising 2-(substituted piperidinomethyl) propane- and propene nitriles MERCK & CO. INC. (US) 1981-03-04 EP disclosed
US-4254131-A Treatment of pain, fever, and inflammation with compositions containing 2-(substitutedpiperidinomethyl)propane and propene nitriles MERCK & CO., INC. (US) 1981-03-03 US disclosed
US-4247700-A MICROBIOCIDES MERCK & CO., INC. (US) 1981-01-27 US disclosed